ORKAOruka Therapeutics

Median target
$155.5
calls from the last 12 months
Implied return
+59.1%
median target vs. price
Coverage
14 analysts · 16 calls
updated in the last 12 months
Consensus
14/0/0+14 net
Buy / Hold / Sell

Which analysts are behind ORKA's consensus?

See every current rating, price target and the analysts' track records for Oruka Therapeutics — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 14 analysts with calls on ORKA updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

ORKA elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-15InsidersGoncalves JoanaChief Medical OfficerInsider sale3.1K sh @ $92.03 · planned trade$290K
2026-09-15InsidersKlein Lawrence OttoChief Executive OfficerInsider sale2.5K sh @ $95.71$235K
2026-09-15InsidersGoncalves JoanaChief Medical OfficerInsider sale2.4K sh @ $91.10 · planned trade$217K
2026-09-15InsidersGoncalves JoanaChief Medical OfficerInsider sale1.4K sh @ $92.99 · planned trade$127K
2026-09-15InsidersQuinlan Paul TGeneral CounselInsider sale1.0K sh @ $95.71$99K
2026-09-15InsidersGoncalves JoanaChief Medical OfficerInsider sale947 sh @ $95.71 · planned trade$91K
2026-09-15InsidersSandler Laura LeeChief Operating OfficerInsider sale906 sh @ $95.71$87K
2026-09-15InsidersAgarwal ArjunSenior Vice President, FInsider sale560 sh @ $95.71 · planned trade$54K
2026-09-15InsidersGoncalves JoanaChief Medical OfficerInsider sale100 sh @ $94.22 · planned trade$9K
2026-09-11InsidersAgarwal ArjunSenior Vice President, FInsider sale4.1K sh @ $92.41 · planned trade$374K

More: insider activity · executive branch · trending